Open Access

Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model

  • Authors:
    • Xuwen Luo
    • Xuqiang Liu
    • Qianyuan Tao
    • Cong Yao
    • Fuqiang Wang
    • Zhiping Gu
    • Feilong Li
    • Xiaolong Yu
    • Bin Zhang
    • Hongxian Fan
    • Min Dai
    • Tao Nie
  • View Affiliations

  • Published online on: May 21, 2020     https://doi.org/10.3892/ol.2020.11656
  • Pages: 1400-1408
  • Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Osteosarcoma is the most prevalent primary bone malignancy in children and adolescents. Neoadjuvant chemotherapy combined with surgical resection, the current standard treatment of osteosarcoma, is associated with a 5‑year survival rate of only ~70%. Therefore, it is necessary to identify new, more effective treatment strategies for patients with this lethal disease. Enoxacin is a highly effective broad‑spectrum fluoroquinolone antibiotic with low toxicity. The drug inhibits the growth and metastasis of numerous tumour types, but its efficacy has not been studied in osteosarcoma. This study assessed the antitumour effects of enoxacin in osteosarcoma 143B cells and in a murine tumour xenograft model. Enoxacin inhibited the proliferation, invasion and migration of 143B cells, as well as inducing their apoptosis. These effects were thought to be mediated by downregulation of Bcl‑xL, Bxl‑2, matrix metalloproteinase (MMP)2 and MMP9 expression. Enoxacin also significantly impaired the growth of bone tumours in nude mice without affecting their liver or kidney function, or blood cell count. Collectively, these results indicate that enoxacin is a promising new drug for osteosarcoma that warrants further evaluation in clinical studies.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Luo, X., Liu, X., Tao, Q., Yao, C., Wang, F., Gu, Z. ... Nie, T. (2020). Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model. Oncology Letters, 20, 1400-1408. https://doi.org/10.3892/ol.2020.11656
MLA
Luo, X., Liu, X., Tao, Q., Yao, C., Wang, F., Gu, Z., Li, F., Yu, X., Zhang, B., Fan, H., Dai, M., Nie, T."Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model". Oncology Letters 20.2 (2020): 1400-1408.
Chicago
Luo, X., Liu, X., Tao, Q., Yao, C., Wang, F., Gu, Z., Li, F., Yu, X., Zhang, B., Fan, H., Dai, M., Nie, T."Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model". Oncology Letters 20, no. 2 (2020): 1400-1408. https://doi.org/10.3892/ol.2020.11656